Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polyps 2Lung Neoplasms 2Pancreatic Pseudocyst 1Lymphoma, Primary Effusion 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Hyperplasia 1Gastroesophageal Reflux 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenomatous Polyposis Coli 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 2Uterine Myomectomy 1Suppositories 1Sennosides 1Propofol 1Midazolam 1Metoclopramide 1Fentanyl 1Everolimus 1Erythromycin 1Eicosapentaenoic Acid 1Diatrizoate Meglumine 1Colonoscopy 1Colonography, Computed Tomographic 1Cholecalciferol 1Calcium Carbonate 1Bisacodyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Polyps × Endoscopy × Clear all
NCT02754661 2019-10-01

TOPAZ

Medtronic - MITG

Phase NA Completed
320 enrolled 15 charts

Polyps

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡